These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 8952541

  • 41. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM.
    Cancer Res; 2002 Apr 01; 62(7):1952-5. PubMed ID: 11929809
    [Abstract] [Full Text] [Related]

  • 42. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.
    Hamano K, Esumi M, Igarashi H, Chino K, Mochida J, ISHIDA And H, Okada K.
    J Urol; 2002 Feb 01; 167(2 Pt 1):713-7. PubMed ID: 11792959
    [Abstract] [Full Text] [Related]

  • 43. Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
    Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018
    [Abstract] [Full Text] [Related]

  • 44. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
    Vortmeyer AO, Huang SC, Koch CA, Governale L, Dickerman RD, McKeever PE, Oldfield EH, Zhuang Z.
    Cancer Res; 2000 Nov 01; 60(21):5963-5. PubMed ID: 11085513
    [Abstract] [Full Text] [Related]

  • 45. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
    Trotta AM, Santagata S, Zanotta S, D'Alterio C, Napolitano M, Rea G, Camerlingo R, Esposito F, Lamantia E, Anniciello A, Botti G, Longo N, Botti G, Pignata S, Perdonà S, Scala S.
    J Exp Clin Cancer Res; 2018 Dec 04; 37(1):297. PubMed ID: 30514329
    [Abstract] [Full Text] [Related]

  • 46. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.
    Gallou C, Joly D, Méjean A, Staroz F, Martin N, Tarlet G, Orfanelli MT, Bouvier R, Droz D, Chrétien Y, Maréchal JM, Richard S, Junien C, Béroud C.
    Hum Mutat; 1999 Dec 04; 13(6):464-75. PubMed ID: 10408776
    [Abstract] [Full Text] [Related]

  • 47. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
    Tibbs RE, Bowles AP, Raila FA, Fratkin JD, Hutchins JB.
    Neurosurgery; 1997 Apr 04; 40(4):848-55; discussion 855. PubMed ID: 9092862
    [Abstract] [Full Text] [Related]

  • 48. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS, Gu YF, Wolff N, Stefanius K, Christie A, Dey A, Hammer RE, Xie XJ, Rakheja D, Pedrosa I, Carroll T, McKay RM, Kapur P, Brugarolas J.
    Proc Natl Acad Sci U S A; 2014 Nov 18; 111(46):16538-43. PubMed ID: 25359211
    [Abstract] [Full Text] [Related]

  • 49. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.
    Vortmeyer AO, Huang SC, Pack SD, Koch CA, Lubensky IA, Oldfield EH, Zhuang Z.
    Oncogene; 2002 Feb 14; 21(8):1167-70. PubMed ID: 11850836
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M, Delahunt B, Störkel S, Grebem SK.
    Cancer Res; 2001 Jun 15; 61(12):4815-9. PubMed ID: 11406557
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
    Lieubeau-Teillet B, Rak J, Jothy S, Iliopoulos O, Kaelin W, Kerbel RS.
    Cancer Res; 1998 Nov 01; 58(21):4957-62. PubMed ID: 9810005
    [Abstract] [Full Text] [Related]

  • 57. Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene.
    Los M, Zeamari S, Foekens JA, Gebbink MF, Voest EE.
    Cancer Res; 1999 Sep 01; 59(17):4440-5. PubMed ID: 10485495
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D.
    Acta Cytol; 1994 Sep 01; 38(5):671-5. PubMed ID: 8091895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.